Fundz

A Dvantage Therapeutics, Inc. reported raising $13.7 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEJun 24, 2021

Amount Raised

$13.7 Million

$13.7 Million sold, per SEC Form D (first sale Jun 24, 2021)

Round Type

Venture

MiamiHealthcareHealth Care

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as ADvantage Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Reimagine Care raised $5.3M on August 6, 2021.
  • Hygieia raised $1.8M (Seed) on August 5, 2021.
  • Mixlab raised $20M (Funding Round) on August 2, 2021.
  • VitalFlo raised $2.1M (Seed) on July 30, 2021.
  • Village Practice Management Company raised $30M on July 30, 2021.
  • Edwards Lifesciences raised $100K (Pre-Seed) on July 27, 2021.

Who to call at ADvantage Therapeutics, and when

A new round usually means ADvantage Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ADvantage Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ADvantage Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ADvantage Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ADvantage Therapeutics

Location

195 NW 40th Street

Miami, Florida, United States

About

ADvantage Therapeutics is a clinical-stage biopharmaceutical company headquartered in the Wynwood neighborhood of Miami, focused on developing therapies for neurodegenerative diseases, with a primary emphasis on Alzheimer’s disease. Its lead candidate, AD04™, is an injectable immunomodulatory therapy preparing to enter confirmatory Phase 2b clinical trials in Europe to assess its safety and efficacy in early Alzheimer’s patients. Unlike treatments that target protein aggregation after disease onset, AD04™ is designed to stimulate and regulate the immune system to reduce Alzheimer’s pathology earlier in the disease process. The company is also actively pursuing additional therapeutic strategies that aim to address neurodegeneration and support healthier longevity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ADvantage Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJeffrey M., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ADvantage Therapeutics's next move

See what Strategic adds

ADvantage Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.